Abstract
The changes driven by feto-placental unit in maternal organism, tantamount to a cardiovascular and metabolic stress test. The adaptative mechanisms that accommodate energy and nutritional requirements for the placenta and the fetus modify glucose-insulin balance as well as gluconeogenesis and lipid metabolism. The microbiota follows the same purpose. When these changes meet with an unbalanced diet, as typical as the Western supermarket diet, adaptative mechanisms turn into an accelerated metabolic syndrome. Unfortunately, this condition adds its risk factors to the pro-inflammatory TH1 milieu of late gestation. In fact, in late gestation villi crowding and reduced intervillous space produce an oxidative stress similar to that produced since early gestation in the case of shallow trophoblastic invasion (i.e., preeclampsia associated with fetal growth restriction). Decidual vascular atherosis might be nurtured by dyslipidemia of metabolic syndrome to an even worse intervillous perfusion. Increased venous abdominal pressure is enhanced by visceral fat and multiplies its impact on renal venous pressure and the renin-angiotensin-aldosterone balance. All these factors conjure to damage either the energy metabolism (gestational diabetes) or the endothelial function into hypertension and various end-organ damage (preeclampsia with normal grown fetus).
This insight might turn upside and become an opportunity of lifestyle changes. Macro-ethnicity, cultural values, nutritional traditions and family habits, individual intolerance to food, lactose non-persistence, gastrointestinal signs and symptoms – all these elements should be investigated and become the background for nutritional and lifestyle advice to tackle present and future health risks for the mother, her health in advanced age, the fetus and the future adult.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia. Placenta. 2014;35(S):S20–5 Elsevier Ltd.
Dunsworth HM, Warrener AG, Deacon T, Ellison PT, Pontzer H. Metabolic hypothesis for human altriciality. Proc Natl Acad Sci U S A. 2012;109(38):15212–6.
Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(5 Suppl):1256S–61.
Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess (Full Rep). 2012;(210):1–327. Review.
Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. New Engl J Med. 2008;358(19):1991–2002.
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80. Elsevier.
Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262–7.
Cetin I, Koletzko B. Long-chain [omega]-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care. 2008;11(3):297–302.
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101.
Zhang C, Ning Y. Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence. Am J Clin Nutr. 2011;94(6 Suppl):1975S–9.
Wood LEP. Obesity, waist-hip ratio and hunter-gatherers. BJOG: Br J Obstet Gynaecol. 2006;113(10):1110–6.
Song S, Lee JE, Song WO, Paik HY, Song Y. Carbohydrate intake and refined-grain consumption are associated with metabolic syndrome in the Korean adult population. J Acad Nutr Diet. 2014;114(1):54–62.
Odegaard AO, Koh WP, Butler LM, Duval S, Gross MD, Yu MC, Yuan JM, Pereira MA. Dietary patterns and incident Type 2 diabetes in Chinese men and women: the Singapore Chinese Health Study. Diabetes Care. 2011;34(4):880–5.
Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, et al. Convergent adaptation of human lactase persistence in Africa and Europe. Nat Genet. 2006;39(1):31–40.
Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care. 2007;30(9):2287–92.
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.
Zhang C, Tobias DK, Chavarro JE, Bao W, Wang D, Ley SH, et al. Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. BMJ. 2014;349:g5450.
Han S, Crowther CA, Middleton P, Heatley E. Different types of dietary advice for women with gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD009275. DOI: 10.1002/14651858.CD009275.pub2.
Asemi Z, Samimi M, Tabassi Z, Esmaillzadeh A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial. Eur J Clin Nutr. 2014;68(4):490–5.
Asemi Z, Samimi M, Tabasi Z, Talebian P, Azarbad Z, Hydarzadeh Z, et al. Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial. J Matern Fetal Neonatal Med. 2012;25(9):1552–6.
Muchmore EA, Diaz S, Varki A. A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol. 1998;107(2):187–98.
Martin MJ, Rayner JC, Gagneux P, Barnwell JW, Varki A. Evolution of human-chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid. Proc Natl Acad Sci U S A. 2005;102(36):12819–24.
Ajit V. Human evolution: details of being human. Nature. 2008;454(7200):21–3.
Lindsay KL, Walsh CA, Brennan L, McAuliffe FM. Probiotics in pregnancy and maternal outcomes: a systematic review. J Matern Fetal Neonatal Med. 2013;26(8):772–8.
Laitinen K, Poussa T, Isolauri E, the Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr. 2008;101(11):1679.
Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counseling during pregnancy on colostrum adiponectin concentration: a prospective, randomized, placebo-controlled study. Early Hum Dev. 2012;88(6):339–44.
Barrett HL, Dekker Nitert M, Conwell LS, Callaway LK. Probiotics for preventing gestational diabetes. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD009951. DOI: 10.1002/14651858.CD009951.pub2.
Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science: Am Assoc Advan Sci. 2005;307(5717):1915–20.
Myatt L, Redman CW, Staff AC, Hansson S. Strategy for standardization of preeclampsia research study design. Hypertension. 2014;6332(6):1293–301.
Burton GJ, Woods AW, Jauniaux E, Kingdom JCP. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2010;30(6):473–82.
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–44.
Sohlberg S, Stephansson O, Cnattingius S, Wikström A-K. Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens. 2010;25(1):120–5.
Mbah AK, Kornosky JL, Kristensen S, August EM, Alio AP, Marty PJ, et al. Super-obesity and risk for early and late pre-eclampsia. BJOG Br J Obstet Gynaecol. 2010;117(8):997–1004.
De Paco C, Kametas N, Rencoret G, Strobl I, Nicolaides KH. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol. 2008;111(2 Pt 1):292–300.
Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52(5):873–80.
Romundstad PRP, Magnussen EBE, Smith GDG, Vatten LJL. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122(6):579–84.
Sara Z, Enrico F, Tamara S, Maria Luisa M, Eleonora R, Valeria M. Maternal and fetal phenotypes in hypertensive disorders of pregnancy are greater determinants of perinatal outcome than gestational age at onset of hypertension. Reproductive Sciences. 2014;1–2.
Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11(5):309–16.
Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Maternal medicine: morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG Br J Obstet Gynaecol. 2006;113(5):580–9.
Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31(1):387–411.
Staff AC, Redman CWG. IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease. Placenta. 2014;35(S):S26–31, Elsevier Ltd.
Le Ray C, Scherier S, Anselem O, Marszalek A, Tsatsaris V, Cabrol D, et al. Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years or older. Hum Reprod. 2012;27(3):896–901.
Schonkeren D, Swings G, Roberts D, Claas F, de Heer E, Scherjon S. Pregnancy close to the edge: an immunosuppressive infiltrate in the chorionic plate of placentas from uncomplicated egg cell donation. PLoS One. 2012;7(3):e32347. Veitia RA, editor.
Gyselaers W, Mullens W, Tomsin K, Mesens T, Peeters L. Role of dysfunctional maternal venous hemodynamics in the pathophysiology of pre-eclampsia: a review. Ultrasound Obstet Gynecol. 2011;38(2):123–9.
Conde-Agudelo A, Belizan JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. Br J Obstetr Gynecol. 2000;107(1):75–83.
Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 2011;342:d2901.
Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544–e12.
Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323(7323):1213–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ferrazzi, E., Mantegazza, V., Zullino, S., Stampaljia, T. (2015). Gestational Diabetes and Maternogenic Preeclampsia: By-products of the Accelerated Metabolic Syndrome in Pregnancy. In: Ferrazzi, E., Sears, B. (eds) Metabolic Syndrome and Complications of Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-319-16853-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-16853-1_10
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16852-4
Online ISBN: 978-3-319-16853-1
eBook Packages: MedicineMedicine (R0)